At a glance
- Originator GlaxoSmithKline
- Developer ALTANA Pharma; GlaxoSmithKline
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 20 Jun 1995 Discontinued-II for Peptic ulcer in Germany (PO)
- 14 Oct 1994 Discontinued-II for Peptic ulcer in United Kingdom (PO)
- 14 Oct 1994 Discontinued-III for Peptic ulcer in USA (PO)